- Latest week
- 10 Jul 2026
- Close
- 425.600006
- Fair value
- 392.122116
- Next-week expectancy
- Undecided 53.92%
VX1 Chart Pack
Vertex Pharmaceuticals Incorporated
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, VX1 rose 15.83%, moving from 367.45 to 425.60. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 2 of the last 12 weeks. Relative Strength is 8.48 and has improved across the 12-week window. Market Dynamics is 1.16 on the latest week. Next-week expectancy is undecided at 53.92% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 425.60
- 12-Week Change
- 15.83%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 53.92%
- Signal Weeks
- 2 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 8.48
- Market Dynamics
- 1.16
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 425.60
- 12-Week Change
- 15.83%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 53.92%
- Signal Weeks
- 2 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 8.48
- Market Dynamics
- 1.16
Over the latest 12 completed weeks ending 2026-07-10, VX1 rose 15.83%, moving from 367.45 to 425.60. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 2 of the last 12 weeks. Relative Strength is 8.48 and has improved across the 12-week window. Market Dynamics is 1.16 on the latest week. Next-week expectancy is undecided at 53.92% based on similar historical setup states.
Industry Peers
Germany equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| GE9 GENMAB AS N | GER | 10 Jul 2026 | 246.20 | 257.90 | 246.20 | 257.90 | 4.75% |
| HPHA Heidelberg Pharma AG | GER | 10 Jul 2026 | 2.56 | 2.79 | 2.56 | 2.66 | 3.91% |
| B72 AtaiBeckley Inc. | GER | 10 Jul 2026 | 4.46 | 4.72 | 4.24 | 4.60 | 3.14% |
| RGO Regeneron Pharmaceuticals, Inc. | GER | 10 Jul 2026 | 574.00 | 587.60 | 563.50 | 579.30 | 0.92% |
| BBZA BB Biotech AG | GER | 10 Jul 2026 | 33.40 | 33.40 | 33.40 | 33.40 | 0.00% |
| PSH0 Sernova Biotherapeutics Inc | GER | 10 Jul 2026 | 0.08 | 0.09 | 0.08 | 0.08 | 0.00% |
| FYB Formycon AG | GER | 10 Jul 2026 | 19.30 | 19.58 | 18.24 | 18.80 | -2.59% |
| NP5 Newron Pharmaceuticals S.p.A. | GER | 10 Jul 2026 | 13.40 | 13.50 | 12.80 | 13.05 | -2.61% |
| PTP Pentixapharm Holding AG N | GER | 10 Jul 2026 | 2.28 | 2.32 | 2.00 | 2.18 | -4.39% |
| AYJ Valneva SE | GER | 10 Jul 2026 | 2.32 | 2.35 | 2.19 | 2.19 | -5.39% |